English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023

    PARTNERS

    • Tata AIA Life Insurance
    • Hafele
    • Motilal Oswal
    • SMC Global Securities Limited
    • SBI Life
    • DSP Mutual Fund
    Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
    you are here: HomeNewsBusiness

    Panacea Biotec stock spikes on $127.3-million global vaccine orders

    Panacea Biotic shares surged on the bourses-NSE and BSE- after the pharmaceutical firm announced on Monday that it had bagged a long-term supply order from UNICEF and Pan American Health Organisation for supply of its pentavalent vaccine Easyfive-TT.

    Moneycontrol News
    October 11, 2022 / 10:04 AM IST
    Representative Image

    Representative Image

    Shares of biotechnology firm Panacea Biotec opened at Rs 158 on the NSE and at Rs 160 on the BSE on Tuesday as against yesterday's close at Rs 134 after the company announced that it had bagged a $127.3-million contract.

    The long-term order worth over Rs 1,040 crore came from UNICEF and Pan American Health Organisation for the supply of its pentavalent vaccine Easyfive-TT.

    This is a five-in-one vaccine given to infants and young children for active immunisation against five severe diseases like diphtheria, haemophilus influenzae type b, hepatitis-B, pertussis, and tetanus, according to healthcare platform website 1mg.com.

    The order from UNICEF is worth $98.755 million (about Rs 813 crore) for supply of 99.7 million doses during 2023 to 2027, while the $28.55 million (about Rs 235 crore) order from Pan American Health Organisation (PAHO) is for supply of 24.83 million doses in 2023 to 2025, according to a statement from the company.